OOIR: Observatory of International Research

Papers

(The TQCC of Growth Hormone & Igf Research is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Impact of short stature on quality of life: A systematic literature review	33
Crosstalk between the growth hormone/insulin-like growth factor-1 axis and the gut microbiome: A new frontier for microbial endocrinology	26
The effect of combined functional training on BDNF, IGF-1, and their association with health-related fitness in the multiple sclerosis women	16
Pregnancy-associated plasma proteins and Stanniocalcin-2 – Novel players controlling IGF-I physiology	16
Treatment of the adult growth hormone deficiency syndrome with growth hormone: What are the implications for other hormone replacement therapies for hypopituitarism?	11
Digital technologies to improve the precision of paediatric growth disorder diagnosis and management	11
Economic and clinical burden of comorbidities among patients with acromegaly	10
Safety, tolerability, pharmacokinetics, and pharmacodynamics of macimorelin in healthy adults: Results of a single-dose, randomized controlled study	9
Molecular and cellular effects of insulin-like growth factor-1 and LongR3-IGF-1 on in vitro maturation of bovine oocytes: comparative study	9
Hormonal stress responses of growth hormone and insulin-like growth factor-I in highly resistance trained women and men	9
Adult growth hormone deficiency: Optimizing transition of care from pediatric to adult services	9
Mechanisms of putative IGF-I receptor resistance in active acromegaly	8
Adherence and long-term outcomes of therapy in paediatric patients in Greece using the easypod™ electromechanical device for growth hormone treatment: The phase IV multicentre easypod™ connect observa	8
Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis	8
Growth hormone replacement may influence the biological action of thyroid hormone on liver and bone tissue	7
Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children	7
A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury	7
Biochemical discrepancies in the evaluation of the somatotroph axis: Elevated GH or IGF-1 levels do not always diagnose acromegaly	7
Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in p	7
Potential applications for rhIGF-I: Bone disease and IGF I	7
Endoplasmic reticulum stress induces growth retardation by inhibiting growth hormone IGF-I axis	6
Growth hormone deficiency, acromegaly and COVID-19: Transitioning from media reports to knowledge and a growth hormone hypothesis	6
Long-term endocrinological outcomes of gamma knife radiosurgery in acromegaly patients	6
The association between treatment and systemic inflammation in acromegaly	6
Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas	6

Growth of teeth and bones in adult subjects with congenital untreated isolated growth hormone deficiency	5
Risk factors associated with thyroid nodular disease in acromegalic patients: A case-cohort study in a tertiary center	5
Dental arches in inherited severe isolated growth hormone deficiency	5
Analyzing structural differences between insulin receptor (IR) and IGF1R for designing small molecule allosteric inhibitors of IGF1R as novel anti-cancer agents	5
Childhood growth hormone deficiency, a diagnosis in evolution: The intersection of growth hormone history and ethics	5
Effects of high-dose all-trans retinoic acid on longitudinal bone growth of young rats	5
Efficacy and predictors of short-term first-generation somatostatin analog presurgical treatment in acromegaly: A hospital-based study of 237 cases	5
Growth hormone secreting pituitary carcinomas: Case report and review of literature	4
Exercise combined with lysine-inositol vitamin B12 promotes height growth in children with idiopathic short stature	4
The effect of milk and rapeseed protein on growth factors in 7–8 year-old healthy children – A randomized controlled trial	4
The involvement of Sestrin2 in the effect of IGF-I and leucine on mTROC1 activity in C2C12 and L6 myocytes	4
Prevalence of thyroid cancer in patients with acromegaly and non-growth hormone secreting pituitary adenomas: A prospective cross-sectional study	4
Adult height and long-term outcomes after rhIGF-1 therapy in two patients with PAPP-A2 deficiency	4
Reduced exercise-induced growth hormone secretion among children with attention-deficit hyperactivity disorder	4